Y, P., Y, L., H, H., C, W., X, H., H, H., . . . Z, Y. (2025). Quantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis. The Laryngoscope, 135(1), 257. https://doi.org/10.1002/lary.31706
Chicago Style (17th ed.) CitationY, Pan, et al. "Quantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis." The Laryngoscope 135, no. 1 (2025): 257. https://doi.org/10.1002/lary.31706.
MLA (9th ed.) CitationY, Pan, et al. "Quantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis." The Laryngoscope, vol. 135, no. 1, 2025, p. 257, https://doi.org/10.1002/lary.31706.
Warning: These citations may not always be 100% accurate.